Page 53 - Read Online

Striano. J Transl Genet Genom 2024;8:278-80 https://dx.doi.org/10.20517/jtgg.2024.40 Page 280

nuanced genetic architecture of these conditions. Integrating research findings into clinical practice will
enhance personalized medicine approaches, ensuring that treatment strategies are tailored to the
individual's genetic profile. The exploration of environmental and epigenetic factors will also be vital in
comprehending the full scope of these disorders.

In conclusion, this Special Issue is not an endpoint but a beacon, guiding us toward a future where the
mysteries of genetic neurodevelopmental diseases are unraveled, and the lives of those affected are
profoundly improved. Let us carry forward the torch of inquiry, collaboration, and compassion that has
been so vividly ignited within these pages.

DECLARATIONS
Authors’ contributions
The author contributed solely to the article.

Availability of data and materials
Not applicable.

Financial support and sponsorship
None.

Conflicts of interest
The author declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2024.

REFERENCES
1. Aledo-Serrano A, Sánchez-Alcudia R, Toledano R, et al. Developmental and epileptic encephalopathies after negative or inconclusive
genetic testing: what is next? J Transl Genet Genom 2021;5:443-55. DOI
2. Lyulcheva-Bennett E, Blumenow W, O’Connor A, Kelly M, Bennett D, Fattah A. Towards an understanding of the aetiology, genomic
landscape and management of Moebius syndrome. J Transl Genet Genom 2023;7:259-73. DOI
3. Bone M, Goodspeed K, Sirsi D. Epilepsy and electroencephalography in Pitt-Hopkins syndrome. J Transl Genet Genom 2022;6:169-78.
DOI